Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip van den Bosch

Showing results (51-60 of 193) with videos related to

Pageof 20
Sort By:
Insights Into Imaging|July 25, 2019
MRI of the axial skeleton in spondyloarthritis: the many faces of new bone formationFrederiek Laloo, Nele Herregods, Jacob L Jaremko, et al.
Rheumatology and Therapy|November 16, 2017
Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 StudyHasan Tahir, Atul Deodhar, Mark Genovese, et al.
European Journal of Radiology|December 12, 2018
New bone formation in the intervertebral joint space in spondyloarthritis: An MRI studyFrederiek Laloo, Nele Herregods, Jacob L Jaremko, et al.
RMD Open|December 31, 2025
Patient-tailored training programme on cardiorespiratory fitness, trunk strength and mobility leads to significantly better outcomes in individuals with axial spondyloarthritisSophie De Mits, Tine Willems, Patrick Calders, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2019
Expert consensus: practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathiesGaëlle Varkas, Clio Ribbens, Edouard Louis, et al.
Annals of the Rheumatic Diseases|May 10, 2014
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohortSofia Ramiro, Désirée van der Heijde, Astrid van Tubergen, et al.
RMD Open|July 15, 2025
Measurement properties of disease activity instruments in peripheral spondyloarthritis: a post-hoc analysis of the CRESPA trialClementina López-Medina, Dafne Capelusnik, Casper Webers, et al.
RMD Open|July 13, 2016
Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritisPhilippe Carron, Bieke Lambert, Liesbet Van Praet, et al.
The Journal of Rheumatology|March 15, 2024
Maximal Exercise Tolerance, Objective Trunk Strength, and Mobility Measurements in Axial SpondyloarthritisSophie De Mits, Tine M Willems, Patrick Calders, et al.
The Journal of Rheumatology|April 15, 2024
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)Gerd R Burmester, Filip Van den Bosch, John Tesser, et al.
Pageof 20

Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
Insights Into Imaging|July 25, 2019
MRI of the axial skeleton in spondyloarthritis: the many faces of new bone formationFrederiek Laloo, Nele Herregods, Jacob L Jaremko, et al.
Rheumatology and Therapy|November 16, 2017
Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 StudyHasan Tahir, Atul Deodhar, Mark Genovese, et al.
European Journal of Radiology|December 12, 2018
New bone formation in the intervertebral joint space in spondyloarthritis: An MRI studyFrederiek Laloo, Nele Herregods, Jacob L Jaremko, et al.
RMD Open|December 31, 2025
Patient-tailored training programme on cardiorespiratory fitness, trunk strength and mobility leads to significantly better outcomes in individuals with axial spondyloarthritisSophie De Mits, Tine Willems, Patrick Calders, et al.
Alimentary Pharmacology & Therapeutics|October 26, 2019
Expert consensus: practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathiesGaëlle Varkas, Clio Ribbens, Edouard Louis, et al.
Annals of the Rheumatic Diseases|May 10, 2014
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohortSofia Ramiro, Désirée van der Heijde, Astrid van Tubergen, et al.
RMD Open|July 15, 2025
Measurement properties of disease activity instruments in peripheral spondyloarthritis: a post-hoc analysis of the CRESPA trialClementina López-Medina, Dafne Capelusnik, Casper Webers, et al.
RMD Open|July 13, 2016
Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritisPhilippe Carron, Bieke Lambert, Liesbet Van Praet, et al.
The Journal of Rheumatology|March 15, 2024
Maximal Exercise Tolerance, Objective Trunk Strength, and Mobility Measurements in Axial SpondyloarthritisSophie De Mits, Tine M Willems, Patrick Calders, et al.
The Journal of Rheumatology|April 15, 2024
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)Gerd R Burmester, Filip Van den Bosch, John Tesser, et al.
Pageof 20